Centessa Pharmaceuticals Announces Poster Presentation Featuring Novel Orexin Receptor 2 (OX2R) Agonist Discovery Pipeline at the 26th Conference of the European Sleep Research Society (Sleep Europe 2022)

September 20, 2022

https://www.globenewswire.com/news-release/2022/09/20/2519238/0/en/Centessa-Pharmaceuticals-Announces-Poster-Presentation-Featuring-Novel-Orexin-Receptor-2-OX2R-Agonist-Discovery-Pipeline-at-the-26th-Conference-of-the-European-Sleep-Research-Socie.html

– Data demonstrate potent efficacy of small-molecule OX2R agonists in a non-clinical model of narcolepsy type 1 (NT1) –
– Company recognizes World Narcolepsy Day on September 22nd –

Read more at globenewswire.com

Related news for (CNTA)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.